References
- DemaerschalkBMHwangHMLeungGUS cost burden of ischemic stroke: a systematic literature reviewAm J Manag Care201016752553320645668
- RothwellPMAlgraAAmarencoPMedical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic strokeLancet201137797781681169221571151
- BonatiLHDobsonJFeatherstoneRLLong-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: the International Carotid Stenting Study (ICSS) randomised trialLancet2015385996752953825453443
- ManteseVATimaranCHChiuDBeggRJBrottTGCREST InvestigatorsThe carotid revascularization endarterectomy versus stenting trial (CREST): stenting versus carotid endarterectomy for carotid diseaseStroke20104110S31S3420876500
- BrottTGHobsonRWHowardGStenting versus endarterectomy for treatment of carotid-artery stenosisN Engl J Med20103631112320505173
- BonatiLHDobsonJAlgraAShort-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient dataLancet201037697461062107320832852
- ShinYSKimBMSuhSHWingspan stenting for intracranial atherosclerotic stenosis: clinical outcomes and risk factors for in-stent restenosisNeurosurgery201372459660423277374
- WasserKSchnaudigelSWohlfahrtJClinical impact and predictors of carotid artery in-stent restenosisJ Neurol201225991896190222318354
- MoriceMCSerruysPWSousaJEA randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularizationN Engl J Med2002346231773178012050336
- KedhiEJoesoefKSMcFaddenESecond-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trialLancet2010375971020120920060578
- ShuchmanMDebating the risks of drug-eluting stentsN Engl J Med2007356432532817251527
- StoneGWMosesJWEllisSGSafety and efficacy of sirolimus and paclitaxel eluting coronary stentsN Engl J Med200735610998100817296824
- HharifFHynesSOCooneyRGene-eluting stents: adenovirus-mediated delivery of eNOS to the blood vessel wall accelerates re-endothelialization and inhibits restenosisMol Ther200816101674168018714308
- LiuJXuYYangQReduction biodegradable brushed PDMAEMA derivatives synthesized by atom transfer radical polymerization and click chemistry for gene deliveryActa Biomater2013987758776623660547
- SharifFHynesSOMcMahonJGene-eluting stents: comparison of adenoviral and adeno-associated viral gene delivery to the blood vessel wall in vivoHum Gene Ther200617774175016839273
- BontaPIPolsTWvan TielCMNuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammationCirculation2010121182023203220421523
- TakahashiMGenetic susceptibility to restenosis: role of bone marrow cells and inflammatory responseArterioscler Thromb Vasc Biol200929101407140819759370
- ZhuCHYingDJMiJHDevelopment of anti-atherosclerosis tissue engineering blood vessel using zinc finger protein A20 regulated endothelial progenitor cellsBiomaterials200829172628263618377984
- HouCLZhangWWeiYZinc finger protein A20 overexpression inhibits monocyte homing and protects endothelial cells from injury induced by high glucoseGenet Mol Res20111021050105921710455
- ZhuCHYingDJMiJHThe zinc finger protein A20 gene protects endothelial cell from burns serum injuryBurns200430212713315019119
- MaXHibbertBDhaliwalBDelayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitorCardiovasc Res201086233834520167573
- CarterAJAggarwalMKopiaGALong-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary modelCardiovasc Res200463461762415306217
- SchwartzRSHuberKCMurphyJGRestenosis and the proportional neointimal response to coronary artery injury: results in a porcine modelJ Am Coll Cardiol19921922672741732351
- SteigerwaldKMerlSKastratiAThe pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating conceptsBiomaterials200930463263718990438
- LassenJFLong-term safety and efficacy of drug-eluting stentsLancet201137797731213121421459431
- CookSLadichENakazawaGCorrelation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosisCirculation2009120539139919620501
- FishbeinIAlferievIBakayMLocal delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteriesCirculation2008117162096210318413497
- DixitVMGreenSSarmaVTumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxinJ Biol Chem19902655297329782406243
- HeyninckKBeyaertRA20 inhibits NF-kappaB activation by dual ubiquitin-editing functionsTrends Biochem Sci20053011415653317
- LeeEGBooneDLChaiSFailure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient miceScience200028954882350235411009421
- ShembadeNHarhajNSParvatiyarKThe E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20Nat Immunol20089325426218246070
- WertzIEO’RourkeKMZhouHDe-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signallingNature2004430700069469915258597
- WolfrumSTeupserDTanMChenKYBreslowJLThe protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genesProc Natl Acad Sci U S A200710447186011860618006655
- PatelVIDanielSLongoCRA20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasiaFASEB J20062091418143016816117
- DamrauerSMFisherMDWadaHA20 inhibits post- angioplasty restenosis by blocking macrophage trafficking and decreasing adventitial neovascularizationAtherosclerosis2010211240440820430393
- StrehblowCSchusterMMoritzTKirchHCOpalkaBPetriJBMonoclonal antibody-polyethyleneimine conjugates targeting Her-2/neu or CD90 allow cell type-specific nonviral gene deliveryJ Control Release2005102373774715681094
- JinXMeiLSongCImmobilization of plasmid DNA on an anti-DNA antibody modified coronary stent for intravascular site-specific gene therapyJ Gene Med200810442142918213735